Síndrome coronária aguda com supradesnível do segmento ST (2018)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- Subjects: MEDICINA DE EMERGÊNCIA; DOENÇAS CARDIOVASCULARES; SÍNDROME CORONARIANA AGUDA
- Language: Português
- Imprenta:
- Publisher place: Barueri, SP
- Date published: 2018
- Source:
-
ABNT
NICOLAU, José Carlos e FURTADO, Remo Holanda de Mendonça. Síndrome coronária aguda com supradesnível do segmento ST. Cardiologia de emergências em fluxogramas. Tradução . Barueri, SP: Faculdade de Medicina, Universidade de São Paulo, 2018. . . Acesso em: 12 out. 2024. -
APA
Nicolau, J. C., & Furtado, R. H. de M. (2018). Síndrome coronária aguda com supradesnível do segmento ST. In Cardiologia de emergências em fluxogramas. Barueri, SP: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Nicolau JC, Furtado RH de M. Síndrome coronária aguda com supradesnível do segmento ST. In: Cardiologia de emergências em fluxogramas. Barueri, SP: Faculdade de Medicina, Universidade de São Paulo; 2018. [citado 2024 out. 12 ] -
Vancouver
Nicolau JC, Furtado RH de M. Síndrome coronária aguda com supradesnível do segmento ST. In: Cardiologia de emergências em fluxogramas. Barueri, SP: Faculdade de Medicina, Universidade de São Paulo; 2018. [citado 2024 out. 12 ] - Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis TREAT trial
- Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial (vol 3, pg 391, 2018)
- Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF Trial
- Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age Insights From DAPA-HF
- Effect of alirocumab on mortality after acute coronary syndromes an analysis of the ODYSSEY OUTCOMES randomized clinical trial
- Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry
- Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54
- Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
- Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
- Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas